Eddy Smart Home Solutions Ltd. Announces Q2 2026 Financial Results
Enablence Technologies and ShunYun Technology Complete Volume Production Readiness at Vietnam Fab Designed to Support AI Data Centers Growth
SATO Technologies Corp. Reports Second Quarter 2026 Results and Completes Settlement of Senior Secured Debt
IC Group Reports Q2 2026 Results; Revenue Up 26% Year-over-Year, Driven By 97% Organic Growth of Annual Recurring Revenue
Silver Hammer and Stroud Resources Announce up to C$10 Million Brokered Financing in Connection with Silver Frontier Transaction
BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharmaceutical company focused…
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI)…
Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI)…
AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine…
AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine…
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
CORAL GABLES, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
– AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity with anti-inflammatory…
– AB126, an unmodified exosome derived from neural stem cells, shows native therapeutic activity with anti-inflammatory…
– Topline results from this study are expected in early Q1 2024 – Celltrion has…
– Topline results from this study are expected in early Q1 2024 – Celltrion has…
Research will use Myriad’s high-definition MRD testing platform based on whole-genome sequencing SALT LAKE CITY,…
Research will use Myriad’s high-definition MRD testing platform based on whole-genome sequencing SALT LAKE CITY,…
Full ENVASARC accrual expected in Q4 and final data expected in mid-2024 SAN DIEGO, Sept….
Full ENVASARC accrual expected in Q4 and final data expected in mid-2024 SAN DIEGO, Sept….
– Seasoned biopharma medical leader joins Apnimed as it initiates its Phase 3 clinical program…
– Seasoned biopharma medical leader joins Apnimed as it initiates its Phase 3 clinical program…
Planegg/Martinsried, September 18, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology…
Planegg/Martinsried, September 18, 2023. Medigene AG (Medigene, the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology…
Morgan Stanley Fireside Chat Replay Now Available SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) —…